153 related articles for article (PubMed ID: 37246135)
1. The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.
Kaimakliotis HZ; Tachibana I; Woldu S; Labbate C; Jacob J; Murray K; Rose K; Sexton W; Dickstein R; Linehan J; Nieder A; Bjurlin M; Humphreys M; Ghodoussipour S; Quek M; O'Donnell M; Eisner BH; Matin SF; Lotan Y; Feldman AS
Urol Oncol; 2023 Sep; 41(9):387.e1-387.e7. PubMed ID: 37246135
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.
Labbate C; Woldu S; Murray K; Rose K; Sexton W; Tachibana I; Kaimakliotis H; Jacob J; Dickstein R; Linehan J; Nieder A; Bjurlin M; Humphreys M; Ghodoussipour S; Quek M; O'Donnell M; Eisner B; Feldman A; Lotan Y; Matin SF
J Urol; 2023 May; 209(5):872-881. PubMed ID: 36657029
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
Rose KM; Murray KS; Labbate C; Woldu S; Linehan J; Jacob J; Kaimakliotis H; Dickstein R; Feldman A; Matin SF; Lotan Y; Humphreys MR; Sexton WJ
Eur Urol Focus; 2023 Sep; 9(5):807-812. PubMed ID: 37059620
[TBL] [Abstract][Full Text] [Related]
4. Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience.
Rosen GH; Nallani A; Muzzey C; Murray KS
J Urol; 2022 Jun; 207(6):1302-1311. PubMed ID: 35130080
[TBL] [Abstract][Full Text] [Related]
5. Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
Linehan J; Gottlieb J; Woldu SL; Labbate C; Rose K; Sexton W; Kaimakliotis H; Jacob J; Dickstein R; Nieder A; Bjurlin M; Humphreys M; Ghodoussipor S; Quek M; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y; Murray KS
Eur Urol Focus; 2023 Nov; 9(6):1052-1058. PubMed ID: 37263827
[TBL] [Abstract][Full Text] [Related]
6. First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
Jacob JM; Woldu SL; Linehan J; Labbate C; Rose KM; Sexton WJ; Tachibana I; Kaimakliotis H; Nieder A; Bjurlin MA; Humphreys M; Ghodoussipour SB; Quek ML; Johnson B; O'Donnell M; Eisner BH; Feldman AS; Murray KS; Matin SF; Lotan Y; Dickstein RJ
Urol Oncol; 2024 Jan; 42(1):20.e17-20.e23. PubMed ID: 37517898
[TBL] [Abstract][Full Text] [Related]
7. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
8. Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
Woldu SL; Labbate C; Murray KS; Rose K; Sexton W; Tachibana I; Kaimakliotis H; Jacob J; Dickstein R; Linehan J; Nieder A; Bjurlin MA; Humphreys M; Ghodoussipour S; Quek ML; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y
Urol Oncol; 2023 Mar; 41(3):147.e15-147.e21. PubMed ID: 36424224
[TBL] [Abstract][Full Text] [Related]
9. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
Grasso M; Fishman AI; Cohen J; Alexander B
BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
[TBL] [Abstract][Full Text] [Related]
10. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Kleinmann N; Matin SF; Pierorazio PM; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky S; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Stern J; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Adibi M; Amin MB; Seltzer E; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Schoenberg M; Lerner SP
Lancet Oncol; 2020 Jun; 21(6):776-785. PubMed ID: 32631491
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
Shabsigh A; Kleinmann N; Smith AB; Scherr D; Seltzer E; Schoenberg M; Lerner SP
Cancer Chemother Pharmacol; 2021 Jun; 87(6):799-805. PubMed ID: 33677615
[TBL] [Abstract][Full Text] [Related]
12. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
[TBL] [Abstract][Full Text] [Related]
13. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas.
Porta C; Giannatempo P; Rizzo M; Lucarelli G; Ditonno P; Battaglia M
Expert Opin Pharmacother; 2020 Dec; 21(18):2199-2204. PubMed ID: 32870051
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Single-Dose Upper Urinary Tract Instillation of Mitomycin C After Therapeutic Ureteroscopy for Upper Tract Urothelial Carcinoma: A Single-Centre Prospective Non-Randomized Trial.
Gallioli A; Boissier R; Territo A; Vila Reyes H; Sanguedolce F; Gaya JM; Regis F; Subiela JD; Palou J; Breda A
J Endourol; 2020 May; 34(5):573-580. PubMed ID: 32164441
[No Abstract] [Full Text] [Related]
16. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: Systematic review and meta-analysis.
Subiela JD; Territo A; Mercadé A; Balañà J; Aumatell J; Calderon J; Gallioli A; González-Padilla DA; Gaya JM; Palou J; Breda A
Eur J Surg Oncol; 2020 Nov; 46(11):1989-1997. PubMed ID: 32674841
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?
Trail M; Rahman MSW; Broadhurst WJ; Blackmur JP; Sharma A; Chew E; O'Donnell M; Keanie JY; Brush J; Taylor J; Phipps S; Thomas B; Mains EAA; McNeill SA; Leung S; Cutress ML; Laird A
BJU Int; 2023 Jun; 131(6):755-762. PubMed ID: 36495480
[TBL] [Abstract][Full Text] [Related]
20. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection.
Clements T; Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
J Endourol; 2012 Apr; 26(4):398-402. PubMed ID: 22192113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
